Buscar en
Progresos de Obstetricia y Ginecología
Toda la web
Inicio Progresos de Obstetricia y Ginecología Supervivencia del cáncer de mama invasivo en estadio I según el método diagn...
Información de la revista
Vol. 47. Núm. 9.
Páginas 407-413 (Enero 2004)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 47. Núm. 9.
Páginas 407-413 (Enero 2004)
DOI: 10.1016/S0304-5013(04)76028-8
Acceso a texto completo
Supervivencia del cáncer de mama invasivo en estadio I según el método diagnóstico
Survival in stage I invasive breast cancer according to diagnostic method
Visitas
...
I. Ñíguez
Autor para correspondencia
isnise@hotmail.com

Correspondencia: Sargento Ángel Tornel, 7, 1.° B. 30009 Murcia. España
, J.R. Rodríguez-García, J.R. Rodríguez-Hernández, J.J. Parrilla, L. Abad
Departamento de Obstetricia y Ginecología. Hospital Universitario Virgen de la Arrixaca. Murcia. España
Información del artículo
Resumen
Objetivos

Valoración de la utilidad de los programas de cribado en la disminución de la mortalidad por cáncer de mama en estadio I.

Material y métodos

Estudio retrospectivo de 314 mujeres con cáncer de mama en estadio I separadas según el método de detección (lesiones diagnosticadas por palpación frente a lesiones diagnosticadas por mamografía). Estudio estadístico comparando la edad, el tamaño tumoral, la anatomía patológica, el grado de diferenciación, el tratamiento, la recurrencia y la supervivencia.

Resultados

No encontramos diferencias estadísticamente significativas entre ambos grupos en ninguno de los factores analizados, excepto en la supervivencia, que fue mejor en el grupo de lesiones palpables (54,904 frente a 53,170 meses para las lesiones palpables).

Discusión

El principal factor pronóstico es el tamaño tumoral al diagnóstico, independientemente del método diagnóstico.

Palabras Clave:
Carcinoma
Mama
Supervivencia
Cribado mamográfico
Estadio I
Abstract
Objectives

To evaluate the utility of screening programs in decreasing mortality from stage I breast cancer.

Material and methods

We performed a retrospective study of 314 women with stage I breast cancer, divided in two groups by diagnostic method (palpable vs. mammographically detected lesions). Statistical analysis was performed comparing age, tumor size, histopathology, histological grade, treatment, recurrence, and survival.

Results

No significant statistical differences were found between the two groups, except in survival, which was better in the group with palpable lesions (54.904 vs. 53.170 months).

Discussion

The main prognostic factor is tumor size at diagnosis, irrespective of the diagnostic method.

Key Words:
Carcinoma
Breast
Survival
Mammographic screening
Stage I
El Texto completo está disponible en PDF
Bibliografía
[1.]
J. Lombardia, I. Rodríguez, M.C. Carreira.
La mama paso a paso. Guía práctica en patología mamaria, 1.a, pp. 253
[2.]
A. Soran, V.G. Vogel.
Best treatment in primary breast cancer.
Breast J, 5 (1999), pp. 81-93
[3.]
P.R. Rosen, S. Grshen, P.E. Saigo, D.W. Kinne, S.J. Hellman.
A long term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma.
Clin Oncol, 7 (1989), pp. 355-366
[4.]
N. Ichizawa, T. Fukutomi, E. Iwamoto, S. Akashi-Tanaka.
Long term results of T1a, T1b and T1c invasive breast carcinoma in Japanese women: validation of the UICC T1 subgroup classification.
Jpn J Clin Oncol, 32 (2002), pp. 108-109
[5.]
P. Perdue, D. Page, M. Nellestein, C. Salem, C. Galbo, B. Ghosh.
Early detection of breast carcinoma: a comparison of palpable and non palpable lesions.
Surgery, 111 (1992), pp. 656-659
[6.]
E.L. Rosen, E. Sickles, D. Keating.
Capacity of mammography for showing non palpable breast cancer in women with palpable masses in breast.
AJR Am J Roentgenol, 172 (1999), pp. 309-312
[7.]
D.P. Winchester, J.D. Cox.
Standards for diagnosis and treatment in invader breast carcinoma.
CA Cancer J Clin, 48 (1998), pp. 83-107
[8.]
Protocolo n.° 101 de la SEGO. Cáncer de mama. Diagnóstico
[9.]
A. Ancona, L. Caiffa, V. Fazio.
Digital stereotactic breast mocrobiopsy with the mammotom study of 122 cases.
Radiol Med, 101 (2001), pp. 341-347
[10.]
V.J. Zannis, K.M. Aliano.
Evolución del patrón de la práctica del cirujano de mama con desaparición de la biopsia a cielo abierto en las lesiones no palpables.
Am J Surg, 176 (1998), pp. 525-528
[11.]
L. Basset, D.P. Winchester, R.B. Caplan, et al.
Punción biópsica estereotáxica de la mama: informe de la Joint Task Force del American College of Radiology,American College of Surgeons, y College of American Pathologist.
Breast J, 3 (1997), pp. 317-330
[12.]
A. Barth, P.H. Craig, M.J. Silverstein.
Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
Cancer, 79 (1997), pp. 1918-1922
[13.]
Y. Iwasaki, T. Fukutomi, S. Akashi-Tanaka, T. Nanasawa, H. Tsuda.
Axillary node metastasis from T1N0M0 breast cancer: possible avoidance of dissection in a subgroup.
Jpn J Clin Oncol, 28 (1998), pp. 601-603
[14.]
N.S. Goldstein, A. Mani, F. Vicini, J. Ingold.
Prognostic features in patients with stage T1 breast carcinoma and a 0.5-cm or less lymph node metastasis. Significance of lymph node hilar tissue invasion.
Am J Clin Pathol, 111 (1999), pp. 21-28
[15.]
P. Barillari, R. Leuzzi, A. Bassiri-Gharb, F. D’Angelo, P. Aurello, E. Naticchioni.
Ambulatory surgical treatment for breast carcinoma.
Minerva Chir, 56 (2001), pp. 55-59
[16.]
A.R. Sasson, B. Fowble, A.L. Hanlon, M.H. Torosian, G. Freedman, H. Boraas, et al.
Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation.
Cancer, 91 (2001), pp. 1862-1869
[17.]
M. Morrow, J. White, J. Moughan, T. Pajack, J. Sylvester, J.F. Wilson, et al.
Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma.
J Clin Oncol, 19 (2001), pp. 2254-22562
[18.]
R. Fonseca, L.C. Hartmann, I.A. Petersen, et al.
Breast ductal carcinoma.
Ann Intern Med, 127 (1997), pp. 1013-1022
[19.]
E. Dreher, G. Berclaz.
Breast carcinoma-when is mastectomy still appropriate?.
Ther Umsch, 55 (1998), pp. 405-407
[20.]
K. Dalberg, H. Johanson, U. Johanson, L.E. Rutqvist.
A randomized trial of long term adjuvant tamoxifen plus postoperative radiation therapy versus radiation therapy alone for patients with early stage breast carcinoma treated with breast-conserving surgery. Stockholm Breast Cancer Study Group.
Cancer, 82 (1998), pp. 2204-2211
[21.]
R.K. Schmidt-Ullrich, D.e. Wazer, T. CiPetrillo, D.J. Marchant, T.J. Smith, H. Safaii, et al.
Breast conservating therapy for early stage breast carcinoma with outstanding 10-year locoregional control rates: a case for aggressive therapy to the tumor bearing quadrant.
Int J Radiat Oncol Biol Phys, 27 (1993), pp. 545-552
[22.]
P. Barillari, R. Leuzzi, A. Bassiri-Gharb, F. D’Angelo, P. Aurello, E. Naticchioni.
Results of conservative surgery in T1 breast carcinoma. Our experience in 66 treated cases.
Minerva Chir, 49 (1994), pp. 1083-1088
[23.]
J.J. Kelemen 3rd, T. Poulton, M.T. Swartz, I. Jatoi.
Surgical treatment of early-stage breast cancer in the Department of Defense Healthcare System.
J Am Coll Surg, 192 (2001), pp. 293-297
[24.]
B. Rosseel, J. Lamote, S. Van Belle, G. Storme, R. Sacre.
Breastsparing surgery in T1 breast carcinoma.
Acta Chir Belg, 87 (1987), pp. 147-151
[25.]
J. Schmolling, B. Maus, D. Rezek, R. Fimmers, T. Holler, H. Schuller, et al.
Breast preservation versus mastectomy ? recurrence and survival rates of primary breast cancer patients treated at the UFK Bonn.
Eur J Gynaecol Oncol, 18 (1997), pp. 29-33
[26.]
H. Mattig, B. Stubert, R. Schmerler.
Changes in radical surgery of breast carcinoma in the last 20 years.
Zentralbl Chir, 122 (1997), pp. 92-96
[27.]
P.P. Rosen, S. Groshen, P.E. Saigo, D.W. Kinne, S. Hellman.
Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years.
J Clin Oncol, 7 (1989), pp. 1239-1251
[28.]
P.C. Gotzsche, O. Olsen.
Is screening for breast cancer with mammography justifiable?.
[29.]
O. Olsen, P.C. Gotzsche.
Cochrane review on screening for breast cancer with mammography.
Lancet, 358 (2001), pp. 1340-1342
[30.]
R.J. Salmon, B. Asselain, M. Le Gal, et al.
Twelve-years of experience in breast cancer in The Institut Curie: improve of survival and value of systematic mammographic study.
Breast J, 6 (1997), pp. 202-205
[31.]
C.P. McPherson, K.K. Swenson, G. Jolitz, et al.
Survival of women 40-49 years old with breast carcinoma depend on detection method.
Cancer, 79 (1997), pp. 1923-1932
[32.]
J. Lawrence, M.D. Solin, J. Delray, P.H.D. Schultz, B. Howard, M.D. Kessler, et al.
Downstaging of breast carcinomas in older women associated with mammographic screening.
Breast J, 2 (1999), pp. 94
Copyright © 2004. Sociedad Española de Ginecología y Obstetricia
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.